Tenderwize
Back to tender search

Open House Originale Rabattverträge 2025-22 - Aclidiniumbromid

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 29, 2027 · 406 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-22 - Aclidiniumbromid

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

45 / 100

Risk factors

The notice explicitly states this is not a public procurement under EU Directive, thus traditional procurement remedies...

No estimated value or volume commitments provided; actual business volume uncertain.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply of Aclidiniumbromid medicinal products under rebate contracts
  • Contractual conditions are standard and non-negotiable
Show full summary

Open House procedure by Techniker Krankenkasse (TK) and two other German health insurers to conclude rebate contracts (Rabattverträge) under § 130a Abs. 8 SGB V for the active substance Aclidiniumbromid. The procedure is not a public procurement within the meaning of Directive 2014/24/EU but follows an open-house model where any eligible pharmaceutical company can join at any time during the contract period (max. 24 months from 01.10.2025 to 30.09.2027). No estimated value is disclosed. Only pharmaceutical companies with a valid marketing authorization for the relevant medicinal product and established in EU/EEA may participate. Award is based solely on eligibility, not on competitive evaluation.

Risks

The notice explicitly states this is not a public procurement under EU Directive, thus traditional procurement remedies...

No estimated value or volume commitments provided; actual business volume uncertain.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer) as defined in § 4 Abs. 18 AMG with respect to the offered product
  • Company seat must be in Germany, another EU Member State, or EEA state
  • Must hold a valid marketing authorization for the specific medicinal product or be otherwise entitled to market it

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-22 - Aclidiniumbromid

Rebate contracts for Aclidiniumbromid. All eligible pharmaceutical companies may conclude a contract on equal terms. No exclusivity. Continuous enrollment possible.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Sep 29, 2027

Procurement Details

Publication date
18 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
541861-2025

Documents (1)

Similar tenders